参考文献/References:
[1] 高淑娟,张 蓉,郭雪艳,等.门脉CT血管成像联合内镜治疗肝硬化食管胃静脉曲张应用价值研究[J].陕西医学杂志,2021,50(7):807-810.
[2] 田莉婷,刘雪萍,李丹妮,等.加味苓桂术甘汤对脾肾阳虚型肝硬化失代偿期患者生存率的影响[J].陕西中医,2019,40(10):1373-1376.
[3] 徐 陈,蒋 淼.PALBI评分对肝硬化合并急性上消化道出血患者短期预后的预测价值[J].临床肝胆病杂志,2021,37(7):1578-1581.
[4] 饶 利,吴海燕,王 红,等.预后营养指数对ST段抬高型心肌梗死患者疾病严重程度的早期评估价值的初步研究[J].四川大学学报:医学版,2019,50(1):102-105.
[5] 胡天野,任少君,林道超.预后营养因子PNI对老年髋部骨折预后的预测价值[J].实用骨科杂志,2019,25(8):686-689.
[6] Johannet P,Sawyers A,Qian Y,et al.Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer[J].J Immunother Cancer,2020,8(2):1674.
[7] 中华医学会肝病学分会.肝硬化诊治指南[J].中华肝脏病杂志,2019,27(11):846-865.
[8] Marisa B,Muhammad MM,David NJ,et al.Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors[J].Arch Intern Med,2005,165(2):189-192.
[9] Watanabe M,Iwatsuki M,Iwagami S,et al.Prognostic nutritional index predicts outcomes of gastrectomy in the elderly[J].World J Surg,2012,36(7):1632-1639.
[10] 冯静云,陆士奇.肝硬化上消化道出血危险因素及预后[J].锦州医科大学学报,2017,38(6):31-35.
[11] 武彦芳.肝硬化上消化道出血危险因素及预后影响因素分析[J].陕西医学杂志,2015,44(3):340-342.
[12] Salati M,Filippi R,Vivaldi C,et al.The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer[J].Liver Int,2020,40(3):704-711.
[13] Correa-Rodríguez M,Pocovi-Gerardino G,Callejas-Rubio JL,et al.The prognostic nutritional index and nutritional risk index are associated with disease activity in patients with systemic lupus erythematosus[J].Nutrients,2019,11(3):638.
[14] 李 娟,周丽娟,李海霞,等.预后营养指数对肝癌术后患者病情进展的预测价值[J].中国现代普通外科进展,2020,23(12):992-995.
[15] 陈小彬,袁加琪,许召君,等.预后营养指数对肝泡型包虫病患者预后的预测价值[J].临床肝胆病杂志,2021,37(5):1147-1151.
[16] Nair R,Radhakrishnan K,Chatterjee A,et al.Serum albumin as a predictor of functional outcomes following acute ischemic stroke[J].J Vasc Interv Neurol,2018,10(2):65-68.
[17] 李德钊,李 健,郭晓林.白蛋白-胆红素评分对肝硬化食管胃静脉曲张出血患者预后的预测价值[J].临床肝胆病杂志,2021,37(5):1085-1090.
[18] 杨丹红,潘红英,黄益澄,等.肝硬化伴全身炎症反应综合征患者预后影响因素的Logistic回归分析[J].国际流行病学传染病学杂志,2016,43(5):294-299.
[19] 李 瑶,刘 力,谭福雄,等.鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化疗效Meta分析[J].陕西中医,2020,41(9):1329-1334.
[20] Bourke CD,Berkley JA,Prendergast AJ.Immune dysfunction as a cause and consequence of malnutrition[J].Trends Immunol,2016,37(6):386-398
[21] 梁利民,徐鹤翔,郑吉顺,等.中性粒细胞与淋巴细胞比值对失代偿期肝硬化患者预后的评估价值[J].临床肝胆病杂志,2019,35(4):790-795.
[22] 翁奉武,郭丽颖,李秋伟,等.外周血淋巴细胞亚群在慢性HBV感染过程中表达的变化分析[J].临床肝胆病杂志,2020,36(1):65-69.
相似文献/References:
[1]王小芳,张利军.可溶性人髓系细胞触发受体1、可溶性血红蛋白清道夫受体、降钙素原表达水平对肝硬化合并自发性细菌性腹膜炎的诊断价值[J].陕西医学杂志,2021,50(12):1525.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.014]
[2]郭武辉,张 华.血清T淋巴细胞亚群检测在肝硬化合并真菌性血流感染中的诊断价值[J].陕西医学杂志,2021,50(12):1570.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.026]
GUO Wuhui,ZHANG Hua.Diagnostic value of serum T lymphocyte subsets detection in liver cirrhosis complicated with fungal bloodstream infection[J].,2021,50(11):1570.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.026]
[3]樊江浩,王 嘉,万 杰,等.肝硬化门静脉血栓抗凝治疗有效性及安全性Meta分析[J].陕西医学杂志,2023,52(4):487.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.028]
FAN Jianghao,WANG Jia,WAN Jie,et al.Efficacy and safety of anticoagulant therapy for portal vein thrombosis in liver cirrhosis:a meta-analysis[J].,2023,52(11):487.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.028]
[4]刘 杰,闵林玲,潘 金,等.经颈静脉肝内门腔静脉分流术与经皮肝穿刺胃冠状静脉栓塞术治疗肝硬化食管胃底静脉曲张破裂出血疗效对比研究[J].陕西医学杂志,2023,52(9):1191.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.017]
LIU Jie,MIN Linling,PAN Jin,et al.Comparative study of TIPS and PTVE in treatment of esophageal and gastric varices bleeding in liver cirrhosis[J].,2023,52(11):1191.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.017]
[5]王 婷,邹百仓,董 蕾,等.核苷类似物治疗乙型肝炎肝硬化并发食管静脉曲张临床价值研究[J].陕西医学杂志,2024,(5):671.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.021]
WANG Ting,ZOU Baicang,DONG Lei,et al.Value of nucleoside analogues in the treatment of hepatitis B cirrhosis complicated with esophageal varices[J].,2024,(11):671.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.021]